Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Observational Study of Mucopolysaccharidosis Type IIIB (MPS IIIB)

NCT02493998 is registered in ClinicalTrials.gov with Allievex Corporation as lead sponsor.

NCT NCT02493998
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02493998 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Observational Study of Mucopolysaccharidosis Type IIIB (MPS IIIB)
Lead sponsor
Allievex Corporation
Phase
Observational
Overall status
Completed
Start date
November 30, 2015
Completion date
April 30, 2019
Enrollment
22 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

mps 3 b, mps iii b, mucopolysaccharidosis type 3 b, mucopolysaccharidosis type iiib